Clinical trial

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder

NCT00798707

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Desvenlafaxine Succinate Sustained-Release (DVS SR) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-12-01

PhasePHASE3

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

Desvenlafaxine Succinate Sustained-Release (DVS SR)DRUG

placeboDRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

SapporoHokkaido, Japan6 YokohamaKanagawa, Japan3 DallasTexas, United States1 AtlantaGeorgia, United States1 San AntonioTexas, United States1 SeattleWashington, United States1 Salt Lake CityUtah, United States1 MemphisTennessee, United States1 DaytonOhio, United States1 St. PetersburgFlorida, United States1 ColumbiaSouth Carolina, United States1 Beverly HillsCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00798707 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.